NIH-funded research Career grant

Developing a new vaccine to prevent infections in joint replacements

Official title: Biomaterials-based Immunoengineering for Periprosthetic Joint Infection

Funded at Ut Southwestern Medical Center · NIH-11117156 · Data updated 2026-11-12

This study is testing a new type of vaccine designed to help prevent infections that can happen after joint replacement surgeries, using a special material that helps boost your immune system against a common germ called Staphylococcus aureus.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startJune 14, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$194,399
NIH project number5K08AI180362-03
Project IDNIH-11117156 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals undergoing or considering joint replacement surgery who are at risk for periprosthetic joint infections.

Less likely to help

Patients who have already experienced severe complications from joint infections or those who are not candidates for joint replacement surgery may not benefit from this research.

What this research studies

This research focuses on creating a novel vaccine platform to prevent periprosthetic joint infections (PJI), which can occur after joint replacement surgeries. The approach involves using a biodegradable scaffold that releases immune-boosting substances and contains specific antigens to stimulate the body's immune response against Staphylococcus aureus, a common cause of these infections. By recruiting immune cells and enhancing their activity, the goal is to provide better protection against infections that can lead to severe complications. The research will utilize animal models to test the effectiveness of this biomaterials-based vaccine.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of infections following joint replacement surgeries, improving patient outcomes and quality of life.

How similar studies have gone: Previous research has shown promise in using biomaterials for vaccine delivery, but this specific approach to preventing PJI is novel and has not been extensively tested in clinical settings.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Tatara, Alexander Mitchell — Ut Southwestern Medical Center
  • Study coordinator: Tatara, Alexander Mitchell

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.